| |
Baseline |
1 month |
3 months |
6 months |
12 months |
24 months |
| Control group |
Mean (95% CI) |
5.83 (5.23-6.43) |
5.83 (5.23-6.43) |
5.83 (5.23-6.43) |
5.83 (5.23-6.43) |
5.83 (5.23-6.43) |
5.83 (5.23-6.43) |
| Variance |
22.03 |
16.60 |
16.60 |
16.60 |
16.60 |
21.58 |
| Intervention group |
Mean (95% CI) |
5.83 (5.23-6.43) |
5.83 (5.23-6.43) |
5.83 (5.23-6.43) |
5.83 (5.23-6.43) |
5.83 (5.23-6.43) |
8.09 (6.65-9.53) |
| Variance |
22.03 |
22.47 |
16.60 |
16.60 |
16.60 |
21.58 |
| Intervention group |
Covariances
(and correlations) |
Baseline |
|
10.68 (0.48) |
7.70 (0.40) |
6.88 (0.36) |
8.83 (0.46) |
3.80 (0.17) |
| 1 month |
9.49 (0.50) |
|
9.49 (0.49) |
9.49 (0.49) |
9.49 (0.49) |
9.49 (0.43) |
| 3 months |
9.49 (0.50) |
9.49 (0.57) |
|
9.49 (0.57) |
9.49 (0.57) |
9.49 (0.50) |
| 6 months |
9.49 (0.50) |
9.49 (0.57) |
9.49 (0.57) |
|
9.49 (0.57) |
9.49 (0.50) |
| Control group |
12 months |
9.49 (0.50) |
9.49 (0.57) |
9.49 (0.57) |
9.49 (0.57) |
|
9.49 (0.50) |
| 24 months |
9.49 (0.44) |
9.49 (0.50) |
9.49 (0.50) |
9.49 (0.50) |
9.49 (0.50) |
|
1Original coding of the hyperglycaemic episodes was grouped to assist adolescents to estimate their episodes. The midpoint of the range was taken to ensure more
meaningful population mean values such that “1-3 days”=2; “4-6 days”=5, “7-12 days”=10 “12 or more”=13 |
